Background: caffeine has been shown to prevent ultraviolet radiation-induced carcinogenesis and to inhibit growth of melanoma cells in experimental studies. We evaluated the association among caffeine intake, coffee consumption, and melanoma risk among three large cohort studies. Methods: the analysis used data from 89,220 women in the nurses' Health Study ii (1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009), 74,666 women in the nurses ' Health Study (1980, and 39,424 men in the Health Professionals Follow-up Study (1986. We used cox proportional hazards models to estimate the hazard ratios (Hr) with 95% confidence intervals (cis) of melanoma associated with dietary intakes. Results: We documented 2,254 melanoma cases over 4 million person-years of follow-up. after adjustment for other risk factors, higher total caffeine intake was associated with a lower risk of melanoma (≥393 mg/day vs. <60 mg/day: Hr = 0.78, 95% ci = 0.64, 0.96; P trend = 0.048). the association was more apparent in women (≥393 mg/day vs. <60 mg/day: Hr = 0.70, 95% ci = 0.58, 0.85; P trend = 0.001) than in men (Hr = 0.94, 95% ci = 0.75, 1.2; P trend = 0.81), and more apparent for melanomas occurring on body sites with higher continuous sun exposure (head, neck, and extremities; ≥393 mg/day vs. <60 mg/day: Hr = 0.71, 95% ci = 0.59, 0.86; P trend = 0.001) than for melanomas occurring on body sites with lower continuous sun exposure (trunk including shoulder, back, hip, abdomen, and chest; Hr = 0.90, 95% ci = 0.70, 1.2; P trend = 0.60). this pattern of association was similar to that for caffeinated coffee consumption, whereas no association was found for decaffeinated coffee consumption and melanoma risk. Conclusions: increasing caffeine intake and caffeinated coffee consumption is associated with decreased risk of cutaneous malignant melanomas. (Epidemiology 2015;26: 898-908) C utaneous malignant melanoma is a potentially lethal form of skin cancer, and its incidence has been increasing in the United States and worldwide.
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(Epidemiology 2015;26: 898-908) C utaneous malignant melanoma is a potentially lethal form of skin cancer, and its incidence has been increasing in the United States and worldwide. [1] [2] [3] numerous studies have identified solar ultraviolet (UV) radiation as the predominant environmental risk factor for the development of cutaneous melanoma, 4 and the number of UV-induced sunburns is a strong predictor of melanoma incidence. 5 interestingly, caffeine, a stimulant found in high concentrations in coffee, has been shown to inhibit UVinduced sunburn lesions in the epidermis of mice and thus may mimic the effect of a sunscreen. [6] [7] [8] Oral administration of caffeine also has been demonstrated to enhance UV-induced cell apoptosis thereby enhancing the elimination of damaged precancerous cells. [9] [10] [11] in addition, both in vitro and in vivo studies have demonstrated an inhibitory effect of caffeine on the growth of melanoma cells. [12] [13] [14] [15] therefore, there is a good biological rationale for a potential preventive role of caffeine in the development of cutaneous melanoma.
to date, epidemiologic evidence for the association of coffee consumption and risk of cutaneous melanoma has been ambiguous. limited prior studies have yielded conflicting results. Some studies suggested an inverse association between coffee consumption and risk of melanoma, [16] [17] [18] [19] whereas others showed no association. [20] [21] [22] [23] the heterogeneous results may be due to differences in study design and range of coffee consumption and inconsistent control for potential confounders.
Furthermore, the numbers of melanoma cases have been limited in most previous studies. these studies also did not distinguish caffeinated from decaffeinated coffee. [16] [17] [18] [19] [21] [22] [23] it has been documented that the role of sunlight in melanoma differs according to anatomic site, which is supportive of the hypothesis that melanomas may arise through divergent etiologic pathways. 24, 25 However, potential variation in the relationship between coffee consumption and risk of melanoma by anatomic site has been unknown. according to the existing biological evidence for caffeine's protective effect against UVinduced skin cancer, 11 it is plausible that caffeine may have a stronger protective effect against cutaneous carcinogenesis on body sites receiving higher continuous UV radiation versus that on body sites receiving lower continuous UV radiation.
to address the hypothesis that caffeine intake and coffee consumption may be associated with a reduced risk of cutaneous malignant melanoma, we investigated the questions using data from three large cohorts of women and men, including the nurses' Health Study ii (1991-2009), nurses' Health Study , and Health Professionals Followup Study .
METHODS

Study Populations
the nurses' Health Study ii was established in 1989 when 116,430 registered female nurses ages 25-42 years were enrolled using a mailed baseline questionnaire that inquired about medical history and lifestyle practices. the nurses' Health Study was established in 1976 when 121,700 married, registered, female nurses between the ages of 30 and 55 years and residing in the United States at the time of enrollment responded to a baseline questionnaire that included questions about their medical history and lifestyle risk factors. the Health Professionals Follow-up Study was established in 1986 when 51,529 US male health professionals ages 40 to 75 years completed a baseline questionnaire on lifestyle, diet, and newly diagnosed diseases. Biennial questionnaires were used to collect data on disease outcomes and health-related factors in all three cohorts. We previously investigated the association of caffeine intake, coffee consumption, and melanoma risk using data from the nurses' Health Study and Health Professionals Follow-up Study, 20 both of which lacked a detailed investigation for body site information on melanoma and used different cutoffs for caffeine intake levels. thus, we revisited these studies with an additional focus on site-specific melanomas and performed a meta-analysis of all three studies. the institutional review boards of Partners Health care System and Harvard School of Public Health approved this study. We consider the participants' completion and return of the selfadministered questionnaires as informed consent.
Assessment of Melanoma Cases
Participants reported new diagnoses of skin cancer biennially. Permission is obtained from participants to acquire their medical and pathological reports if melanoma is reported. the medical and pathological records were reviewed by physicians who were unaware of exposure status to retrieve information on tumor histology if available. Melanomas were initially classified as the following three subgroups according to tumor location: head/neck melanomas, extremity melanomas (upper extremities between shoulder and hand/fingers, lower extremities between hip and feet), and trunk melanomas (shoulder, back, hip, abdomen, and chest), according to the existing literature that head/neck melanomas may arise through a different causal pathway when compared with trunk melanomas, 25 and extremity melanomas may have a risk factor profile intermediate between the profiles for head/neck melanomas and trunk melanomas. 24, 26 Because the associations with caffeine intake for melanomas of head/neck and extremities were similar, we then collapsed these two subgroups into a single group. in-situ melanomas were defined as early-stage tumors restricted to the epidermis, and invasive melanomas were defined as those that had grown into the dermis or surrounding tissues based on the pathological reports. a detailed body site and histological description for incident melanomas in each study is shown in etable 1 (http://links.lww.com/eDe/a953).
Assessment of Dietary Exposure
the dietary assessment was repeated using a food-frequency questionnaire at least 4 years during the follow-up. Specifically, dietary information was collected in 1991, 1995, 1999, 2003, and 2007 in the nurses ' Health Study ii, in 1980 , 1984 , 1990 , 1994 , 1998 in the nurses' Health Study, and in 1986, 1990, 1994, 1998, 2002, and 2006 in the Health Professionals Follow-up Study. On all food frequency questionnaires, participants were asked how often on average (i.e., never to 6+ servings/day) during the previous year they had consumed caffeinated and decaffeinated coffee ("one cup"), tea ("one cup or glass"), carbonated beverages ("one glass, bottle, or can"), and other food items. carbonated beverages included caffeinated and caffeine-free colas and carbonated soft drinks. We calculated the total caffeine intake by summing the caffeine content for a specific amount of each food during the previous year multiplied by a weight proportional to the frequency of its consumption. Using the foodcomposition database of the US Department of agriculture, we estimated that the caffeine content was 137 mg per cup of caffeinated coffee, 47 mg per cup of caffeinated tea, 46 mg per bottle or can of caffeinated carbonated beverage, and 7 mg per serving of caffeine-containing chocolate. the validity and reproducibility of the food frequency questionnaire has been detailed elsewhere. 27, 28 Specifically, high correlations were found between food frequency questionnaire and diet records for coffee and other caffeine-rich beverage intake (coffee: r = 0.78; tea: r = 0.93; and caffeinated carbonated beverages: r = 0.84). 27, 28 in addition, information on other dietary intakes including total energy and alcohol was also collected using the food frequency questionnaires.
Assessment of Covariates
in the biennial follow-up questionnaires, we inquired and updated information on anthropometric and lifestyle factors for chronic diseases, including body height and weight, cigarette smoking, and physical activity. Data on menopausal status, postmenopausal hormone use, and rotating night shifts were collected in women. 29 Data on the following phenotypic and sun exposure-related factors were collected through the follow-up questionnaires: family history of melanoma in firstdegree relatives (parents and siblings); natural hair color; number of moles on legs (nurses' Health Study ii) or arms (nurses' Health Study and Health Professionals Follow-up Study); skin reaction to sun exposure for 2 hours or more as a child/adolescent; number of severe or blistering sunburns; average time spent in direct sunlight since high school; and cumulative UV flux since baseline. 30, 31 Statistical Analysis a total of 89,220 women in the nurses' Health Study ii, 74,666 women in the nurses' Health Study, and 39,424 men in the Health Professionals Follow-up Study who had completed a dietary questionnaire and had no history of any cancer at baseline were included in this analysis. We used cumulatively updated intakes in analyses to create the best estimates of long-term intake. that is, at the beginning of every 2-year follow-up cycle, each intake was calculated as the mean of all reported intakes up to that time. 32 Participants contributed to follow-up time from the return month of baseline questionnaire to the month of the first diagnosis of a skin cancer (melanoma, squamous cell carcinoma, or basal cell carcinoma), month of death, loss to follow-up, or the end of follow-up (June 2009 for nurses' Health Study ii, June 2008 for nurses' Health Study, and January 2008 for Health Professionals Follow-up Study), whichever came first. We used cox proportional hazards models to estimate the ageadjusted and multivariate hazard ratios (Hrs) with 95% confidence intervals (cis) of incident melanoma associated with dietary intakes. Multivariate analyses for caffeine intake were conducted with adjustment for known melanoma risk factors and potential lifestyle confounders which have been associated with skin cancer risk in previous studies. 29, 30, [33] [34] [35] Missing data during any follow-up period were coded as a missing indicator category for categorical variables (e.g., smoking status) and with carried-forward values for continuous variables (e.g., body mass index). trend tests across categories of dietary intake were performed by assigning median values for these categories and treating the variables as continuous terms in the models. results from different study cohorts were pooled using a random-effect model. P values for heterogeneity between studies were calculated with the use of the Q statistic. We used SaS software version 9.2 (SaS institute inc., cary, nc) for all statistical analyses. all statistical tests were two-tailed, and the significance level was set at P < 0.05.
RESULTS
We documented a total of 2,254 incident melanomas over 4 million person-years of follow-up (nurses' Health Study ii: 642 cases/1,543,932 person-years; nurses' Health Study: 841 cases/1,758,768 person-years; Health Professionals Follow-up Study: 771 cases/663,991 person-years). among women, 199 (13%) melanomas occurred on head and neck, 793 (53%) on extremities, and 457 (31%) on trunk. among men, 233 (30%) melanomas occurred on head and neck, 169 (22%) on extremities, and 307 (40%) on trunk (etable 1; http://links.lww.com/eDe/a953). to control for the heterogeneity in caffeine intake ranges across the study cohorts, we used the caffeine intake quintiles in the nurses' Health Study ii to regroup nurses' Health Study and Health Professionals Follow-up Study participants. table 1 shows the characteristics of study participants by quintiles of caffeine intake in the nurses' Health Study ii. Participants with higher caffeine intake had higher consumption levels of caffeinated coffee, caffeinated tea, and caffeinated carbonated beverages; and were more likely to smoke, drink alcohol, and work in night shifts.
We found an inverse association between increased caffeine intake and risk of melanoma in both the nurses' Health Study ii and nurses' Health Study cohorts (table 2) . after adjustment for other risk factors, the pooled multivariate Hrs for melanoma from the lowest to highest category of caffeine intake in women were 1.00 (reference), 0.84 (95% ci = 0.70, 1.0), 0.90 (95% ci = 0.75, 1.1), 0.80 (95% ci = 0.67, 0.96), and 0.70 (95% ci = 0.58, 0.85; P trend = 0.001). However, the association was not apparent in men (≥393 mg/day vs. <60 mg/day: Hr = 0.94, 95% ci = 0.75, 1.2; P trend = 0.81). Pooled analysis for all three cohorts also suggested an inverse association between caffeine intake and risk of melanoma (≥393 mg/day vs. <60 mg/day: Hr = 0.78, 95% ci = 0.64, 0.96; P trend = 0.048).
interestingly, the inverse association appeared to be more apparent for melanomas occurring on head/neck and extremities than for melanomas occurring on the trunk in all three cohorts. the inverse association for head/neck melanoma was similar with that for extremity melanoma (etable 2; http://links.lww.com/eDe/a953), and the pooled multivariate Hrs for melanoma on head, neck, and extremities comparing the extreme categories of caffeine intake were 0.66 (95% ci = 0.53, 0.83; P trend = 0.001) in women and 0.71 (95% ci = 0.59, 0.86; P trend = 0.001) in women and men combined (table 3) . in contrast, the association trend was not evident for trunk melanoma over the intake categories in the pooled analyses (≥393 mg/day vs. <60 mg/day: Hr = 0.90, 95% ci = 0.70, 1.2, P trend = 0.60).
caffeinated coffee consumption was also inversely associated with risk of melanoma in women, whereas decaffeinated coffee consumption showed no association with risk of melanoma in women ( .9) 5.7 (10) 7.1 (11) 8.9 (14) 12 (15) 13 ( 126 (24) 124 (25) 121 (23) 119 (22) 120 (23) 129 (27) 130 (27) 129 (27) Body mass index (kg/m 2 )
25 (5) 25 (5) 25 (5) 24 (5) 25 (5) 24 (4) 25 (5) 25 (5) 25 (5) current smoking (%) 21 (28) 21 (28) 14 (19) 14 (19) 13 (20) 23 (33) 20 (27) 19 ( ≥25 cigarettes/day), physical activity (quintiles), total energy intake (quintiles), and alcohol intake (none, 0.1-4.9, 5.0-9.9, ≥10.0 g/day). analyses for women were also adjusted for rotating night shifts (never, 1-2, 3-9, ≥10 years) and menopausal status and postmenopausal hormone use (premenopausal, postmenopausal never, past, or current use).
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. for melanoma were 0.86 (95% ci = 0.72, 1.0) for women who consumed less than 1 cup/day, 0.83 (95% ci = 0.70, 0.98) for 1 to 2 cups/day, and 0.76 (95% ci = 0.64, 0.89) for more than 2 cups/day (P trend = 0.001). there was no apparent association for caffeinated coffee consumption and risk of melanoma in men (P trend = 0.55). However, caffeinated coffee consumption appeared to be more strongly associated with melanoma on head, neck, and extremities in all three cohorts (table 5) , and the pooled multivariate Hrs comparing the extreme consumption levels (>2 cups/day vs. never) were 0.70 (95% ci = 0.58, 0.85; P trend < 0.001) in women and 0.74 (95% ci = 0.63, 0.88; P trend < 0.001) for women and men combined. the inverse association for head/neck melanoma was also similar with that for extremity melanoma (etable 3; http://links. lww.com/eDe/a953). in contrast, there was no evident association trend for caffeinated coffee consumption and risk of trunk melanoma over the consumption categories (all pooled P trend > 0.60, table 5). there was no apparent association between decaffeinated coffee consumption and melanoma on either head/neck/extremities or trunk (data not shown). associations of caffeine intake and caffeinated coffee consumption with in-situ and invasive melanomas were generally similar (etables 4 and 5; http://links.lww.com/eDe/ a953). We conducted stratified analyses to evaluate whether the association between caffeine intake and risk of melanoma varied according to potential confounders, such as smoking status, alcohol use, and rotating night shifts in women. results of subgroup analyses suggested associations generally similar to those from the main analyses, and there was no interaction between caffeine intake and these potential confounders (all P interaction > 0.10, data not shown).
DISCUSSION
Based on data from three large, prospective cohorts, we found that higher caffeine intake and caffeinated coffee consumption was associated with a lower risk of cutaneous malignant melanoma. in contrast, no association was found between consumption of decaffeinated coffee and risk of melanoma. Participants in the highest caffeine intake category (≥393 mg/day) had a 22% lower risk of melanoma compared with those in the lowest intake category (<60 mg/day). the inverse association with caffeine intake and caffeinated coffee consumption was more apparent in women than in men, and more apparent for melanomas occurred on head, neck, and extremities than for melanomas occurred on trunk. in contrast, no inverse association was found for melanoma on trunk with caffeinated coffee consumption. these findings are consistent with the existing literature from animal studies showing that caffeine may eliminate sunburned cells by enhancing UV-induced apoptosis and thereby prevent UVinduced carcinogenesis. [6] [7] [8] [9] [10] 36, 37 caffeine may inhibit UV-induced carcinogenesis through several biologic mechanisms. animal studies indicate that caffeine has a sunscreen effect that inhibits UV-induced formation of thymine dimers and sunburn lesions in the epidermis of mice. 7, 11 caffeine administration enhances UV-induced apoptosis by p53-dependent and p53-independent mechanisms. Pretreatment with oral caffeine enhanced UV-induced increases in p53 positive cells, p21 positive cells, and apoptotic sunburn cells. 9 Oral administration of coffee had a similar stimulatory effect on UV-induced apoptosis. 10 However, oral administration of caffeine had no effect on p53, p21, or apoptosis in the absence of UV irradiation, indicating that caffeine enhanced apoptosis only in Dna damaged epidermis but not in normal epidermis. 11 Previous experimental studies in tumor cells have found that caffeine can arrest cell cycle at the g2 checkpoint and preferentially radiosensitize tumor cells, 38, 39 and that the radiosensitizing effects of caffeine are related to inhibition of the protein kinase activities of ataxia telangiectasia mutated and rad3-related (atr). 40 a more recent study further demonstrated that administration of caffeine could enhance the removal of Dna-damaged cells by inhibiting the atr-mediated phosphorylation of checkpoint kinase 1 and prematurely increasing the number of cyclin B1-containing cells that undergo lethal mitosis, and thereby inhibit UVinduced carcinogenesis. 37 in addition, UV-mediated nF-κB activation has been shown to result in acquired resistance to apoptosis and promotes the development of skin cancer, 41, 42 whereas caffeine can inhibit UV-mediated nF-κB activation in melanoma cells. 43 notably, caffeine also has been demonstrated to inhibit the growth of melanoma cells in vitro and in vivo. [12] [13] [14] [15] an early study found that caffeine caused murine melanoma cells treated with cisplatin to differentiate, and this inhibited growth. 12 Further studies found that treatment with caffeine not only can inhibit tumor growth, prevent neovascularization, increase apoptosis of melanoma cells 13 but also can inhibit metastatic behavior of melanoma cells.
14,15 therefore, it is biologically plausible that caffeine intake may play an important role in the prevention of cutaneous melanoma.
the findings of this study are different from those in our previous analysis. 20 Several reasons may help explain the previous null results. First, the ranges of caffeine intake differed between the study cohorts, causing the heterogeneity in the Hrs of higher intake groups versus reference groups over study populations. Specifically, the ranges of the first quintiles were 0-59 mg/day in the nurses' Health Study ii, 0-132 mg/day in the nurses' Health Study, and 0-42 mg/day in the Health Professionals Follow-up Study. table 2 shows the results using nurses' Health Study ii intake quintiles for all three cohorts, and the Hr of the second category 60-140 mg/day versus the first category 0-59 (<60) mg/day was 0.82 (0.62-1.1) in the nurses' Health Study. therefore, when we use the 0-132 mg/day range (equals to <60 mg/day plus 60-140 mg/day approximately) as the reference group for nurses' Health Study, it will diminish the relative risk difference over intake categories and results in null Hr estimates. to control for the heterogeneity in intake ranges over studies, we therefore used the same intake cutoffs for different study cohorts.
Second, we treated melanoma as a single outcome in the previous analysis but did not account for the body site categories (head/neck/extremities vs. trunk) of the tumors. in this study, we performed a more detailed, hypothesis-driven subtype analysis for melanoma, and found that the inverse association among caffeine intake, caffeinated coffee consumption, and risk of melanoma was mainly attributable to melanomas occurred on head, neck, and extremities with higher continuous sun exposure but not melanomas occurred on trunk with lower continuous sun exposure.
third, we also expanded the follow-up period to start from 1980 (instead of 1984 in the previous analysis) in the nurses' Health Study when the first food frequency questionnaire was used to collect diet information in the nurses' Health Study participants, 32 and thus increased the statistical power. Melanoma was first asked in 1982 in the nurses' Health Study, and we sought to validate self-reported melanoma diagnoses during 1980-1982 by medical and pathological records.
the association among caffeine intake, caffeinated coffee consumption, and melanoma risk was not apparent among men in the Health Professionals Follow-up Study, although the inverse association was also more apparent for melanoma on head, neck, and extremities than for melanoma on trunk. this may be due to modest statistical power for men, and a lower proportion of melanoma on head, neck, and extremities and a higher proportion of melanoma on trunk in men than in women (etable 1; http://links.lww.com/ eDe/a953). it is evident that sun exposure patterns differ between women and men. Men generally receive less continuous solar UV radiation on extremities as compared with women because of different dressing styles, thereby resulting in different proportions of extremity melanoma over genders (21.9% in men vs. 53.5% in women). therefore, it is possible that caffeine's protective effect against melanoma among men may not be as apparent as among women when melanoma is treated as a single outcome. Similarly, a previous study from norway also documented an inverse association between coffee consumption and melanoma risk in women but not in men. 18 the norwegian study included 25,049 women and 25,708 men, among whom a total of 108 malignant melanomas were documented. 18 However, this study did not differentiate between caffeinated coffee and decaffeinated coffee and also did not account for the variation in the association by tumor site. the strengths of this study include its prospective design, large sample size, long-term follow-up, detailed melanoma case ascertainment with clear separation for different subtypes, repeated assessments of dietary and lifestyle factors, and the ability to differentiate between caffeinated coffee and decaffeinated coffee. Our study also has several limitations. the cohorts studied mostly comprised white, well-educated health professionals, which potentially limits the generalizability of the findings. However, restricting the sample to health professionals also reduces potential residual confounding from socioeconomic status. in this study, caffeine intake was also positively associated with several lifestyle factors including alcohol intake, smoking status, and rotating night shifts. However, we did not detect appreciable interaction among caffeine intake, coffee consumption, and these potential confounders, suggesting that residual confounding by these variables should not be a substantial concern.
in sum, we found that caffeine intake and caffeinated coffee consumption were inversely associated with risk of cutaneous malignant melanoma based on data from three large cohorts. the association was more apparent in women than in men, and was also more apparent for melanomas occurred on head, neck, and extremities than for melanomas occurred on trunk. We did not find any association between decaffeinated coffee consumption and melanoma risk. these findings are consistent with previous biologic evidence that caffeine may prevent UV-induced carcinogenesis, and support the hypothesis that melanoma on different body sites may arise through divergent causal pathways. [24] [25] [26] given highly prevalent coffee consumption and sun exposure behaviors in the general population and rising melanoma incidence over the decades worldwide, 1-3 our findings may help convey important public health implications, and may be potentially useful for the prevention of sun-induced malignant melanomas.
